Ridgeback Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ridgeback Biotherapeutics's estimated annual revenue is currently $1.7M per year.
- Ridgeback Biotherapeutics's estimated revenue per employee is $155,000
Employee Data
- Ridgeback Biotherapeutics has 11 Employees.
- Ridgeback Biotherapeutics grew their employee count by -8% last year.
Ridgeback Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Ridgeback Biotherapeutics?
Ridgeback Biotherapeutics is a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases. The team at Ridgeback is dedicated to working toward finding life-saving and life changing solutions for patients and diseases that need champions. Headquartered in Miami, Florida, Ridgeback Biotherapeutics is a privately held, majority woman-owned biotechnology company; all funding for Ridgeback Biotherapeutics has originated from Wayne and Wendy Holman; two science driven individuals who invest in technologies that they believe will make the world a better place.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Miami
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 11 | -21% | N/A |
#2 | $1M | 11 | 0% | N/A |
#3 | $1M | 11 | 10% | N/A |
#4 | $0.4M | 11 | 22% | $2.3M |
#5 | $1M | 11 | N/A | N/A |